Page last updated: 2024-08-26

indobufen and 6-ketoprostaglandin f1 alpha

indobufen has been researched along with 6-ketoprostaglandin f1 alpha in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carriero, MR; Cerletti, C; de Gaetano, G; Mussoni, L	1
Celi, V; Chello, M; Colonna, A; Marchese, AR; Mastroroberto, P; Romano, F	1

Trials

1 trial(s) available for indobufen and 6-ketoprostaglandin f1 alpha

Article	Year
Reduction by indobufen of neutrophil activation in peripheral arterial occlusive disease. Journal of cardiovascular pharmacology, 1996, Volume: 27, Issue:3 Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Arterial Occlusive Diseases; Cyclooxygenase Inhibitors; Humans; Intermittent Claudication; Isoindoles; Lactic Acid; Middle Aged; Neutrophil Activation; Phenylbutyrates; Platelet Aggregation Inhibitors; Thromboxane B2	1996

Article

Year

Reduction by indobufen of neutrophil activation in peripheral arterial occlusive disease.

Journal of cardiovascular pharmacology, 1996, Volume: 27, Issue:3

Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Arterial Occlusive Diseases; Cyclooxygenase Inhibitors; Humans; Intermittent Claudication; Isoindoles; Lactic Acid; Middle Aged; Neutrophil Activation; Phenylbutyrates; Platelet Aggregation Inhibitors; Thromboxane B2

1996

Other Studies

1 other study(ies) available for indobufen and 6-ketoprostaglandin f1 alpha

Article	Year
Low dose aspirin does not prevent fibrinolytic response to venous occlusion. Biochemical pharmacology, 1986, Sep-15, Volume: 35, Issue:18 Topics: 6-Ketoprostaglandin F1 alpha; Analysis of Variance; Aspirin; Fibrinolysis; Hematocrit; Humans; Isoindoles; Phenylbutyrates; Thrombosis; Thromboxane B2	1986